Genomics

Dataset Information

0

IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.

ABSTRACT: IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy.

PROVIDER: PRJNA741779 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR14924200.fastq.gz Fastqsanger.gz
SRR14924201.fastq.gz Fastqsanger.gz
SRR14924202.fastq.gz Fastqsanger.gz
SRR14924203.fastq.gz Fastqsanger.gz
SRR14924204.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 49

Similar Datasets

Proteomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
2021-08-10 | PXD026824 | Pride
Proteomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
2021-08-10 | PXD026805 | Pride
Proteomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
2021-08-10 | PXD026842 | Pride
Proteomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
2021-08-10 | PXD026857 | Pride
Proteomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy
2021-08-10 | PXD026844 | Pride
Transcriptomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy [Exp3]
2021-08-09 | GSE178977 | GEO
Transcriptomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy [Exp2]
2021-08-09 | GSE178976 | GEO
Transcriptomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy [Exp1]
2021-08-09 | GSE178975 | GEO
Genomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy [Exp1]
| PRJNA741781 | ENA
Genomics IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy [Exp2]
| PRJNA741783 | ENA